Hikma Strikes $185m Deal For Xellia Injectables Portfolio, Manufacturing Facility

Investment In Ohio Facility Will Allow In-House Production For Xellia Injectables

 
• By Dean Rudge
  
The acquisition deal will double the size of Sosei Group.
• Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Deals

More from Business